glp-1 agonists quizlet Emerging Role of Dual and GIP Receptor | DMSO IUPHAR review – Glucagon-like peptide-1
Description
Additionally, improved glycemic control further enhances these effects, particularly in patients with type 2 diabetes

2024;47(Suppl 1):S14557

The hormone also decreases the parietal cells secretion of gastrin and stomach acid, proliferates the bones osteoblasts and inhibits osteoclasts, and may be involved in neuro-signaling as evidenced by widespread expression of GIPr in the brain

But the medication effect typically depends on continuing the medication

Wiera G, Nowak D, van Hove I, Dziegiel P, Moons L, Mozrzymas JW

Getting Started with Mounjaro Alternatives Heres how to transition from Mounjaro or start fresh with an affordable alternative
